These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31251975)

  • 1. Chronic psychological stress during adolescence induces sex-dependent adulthood inflammation, increased adiposity, and abnormal behaviors that are ameliorated by selective inhibition of soluble tumor necrosis factor with XPro1595.
    Eidson LN; deSousa Rodrigues ME; Johnson MA; Barnum CJ; Duke BJ; Yang Y; Chang J; Kelly SD; Wildner M; Tesi RJ; Tansey MG
    Brain Behav Immun; 2019 Oct; 81():305-316. PubMed ID: 31251975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia.
    Clausen BH; Degn M; Martin NA; Couch Y; Karimi L; Ormhøj M; Mortensen ML; Gredal HB; Gardiner C; Sargent II; Szymkowski DE; Petit GH; Deierborg T; Finsen B; Anthony DC; Lambertsen KL
    J Neuroinflammation; 2014 Dec; 11():203. PubMed ID: 25498129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activation.
    Duque-Wilckens N; Teis R; Sarno E; Stoelting F; Khalid S; Dairi Z; Douma A; Maradiaga N; Hench S; Dharshika CD; Thelen KM; Gulbransen B; Robison AJ; Moeser AJ
    Brain Behav Immun; 2022 Jul; 103():73-84. PubMed ID: 35339629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetes.
    De Sousa Rodrigues ME; Houser MC; Walker DI; Jones DP; Chang J; Barnum CJ; Tansey MG
    Alzheimers Res Ther; 2019 Dec; 12(1):1. PubMed ID: 31892368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression.
    Griepke S; Grupe E; Lindholt JS; Fuglsang EH; Steffensen LB; Beck HC; Larsen MD; Bang-Møller SK; Overgaard M; Rasmussen LM; Lambertsen KL; Stubbe J
    Front Cardiovasc Med; 2022; 9():942342. PubMed ID: 36186984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics.
    Maillet I; Schnyder-Candrian S; Couillin I; Quesniaux VF; Erard F; Moser R; Fleury S; Kanda A; Dombrowicz D; Szymkowski DE; Ryffel B
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):731-9. PubMed ID: 21297077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
    MacPherson KP; Sompol P; Kannarkat GT; Chang J; Sniffen L; Wildner ME; Norris CM; Tansey MG
    Neurobiol Dis; 2017 Jun; 102():81-95. PubMed ID: 28237313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice.
    Novrup HG; Bracchi-Ricard V; Ellman DG; Ricard J; Jain A; Runko E; Lyck L; Yli-Karjanmaa M; Szymkowski DE; Pearse DD; Lambertsen KL; Bethea JR
    J Neuroinflammation; 2014 Sep; 11():159. PubMed ID: 25204558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice.
    Randhi R; Damon M; Dixon KJ
    BMC Gastroenterol; 2021 May; 21(1):243. PubMed ID: 34049483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of Soluble Tumor Necrosis Factor Alters the Neuroinflammatory Response following Moderate Spinal Cord Injury in Mice.
    Lund MC; Ellman DG; Nielsen PV; Raffaele S; Fumagalli M; Guzman R; Degn M; Brambilla R; Meyer M; Clausen BH; Lambertsen KL
    Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection.
    Zalevsky J; Secher T; Ezhevsky SA; Janot L; Steed PM; O'Brien C; Eivazi A; Kung J; Nguyen DH; Doberstein SK; Erard F; Ryffel B; Szymkowski DE
    J Immunol; 2007 Aug; 179(3):1872-83. PubMed ID: 17641054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice.
    Larson K; Damon M; Randhi R; Nixon-Lee N; J Dixon K
    CNS Neurol Disord Drug Targets; 2022 Jun; ():. PubMed ID: 35692164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.
    Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I
    J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn.
    Zhou KX; He XT; Hu XF; Zhao WJ; Li CX; Zhang C; Zhang T; Gu ZX; Deng JP; Dong YL
    Brain Res Bull; 2019 Jul; 149():137-147. PubMed ID: 31002915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
    Madsen PM; Motti D; Karmally S; Szymkowski DE; Lambertsen KL; Bethea JR; Brambilla R
    J Neurosci; 2016 May; 36(18):5128-43. PubMed ID: 27147664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice.
    Yli-Karjanmaa M; Clausen BH; Degn M; Novrup HG; Ellman DG; Toft-Jensen P; Szymkowski DE; Stensballe A; Meyer M; Brambilla R; Lambertsen KL
    Front Neurosci; 2019; 13():781. PubMed ID: 31440125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice.
    Papazian I; Tsoukala E; Boutou A; Karamita M; Kambas K; Iliopoulou L; Fischer R; Kontermann RE; Denis MC; Kollias G; Lassmann H; Probert L
    J Neuroinflammation; 2021 Sep; 18(1):222. PubMed ID: 34565380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex.
    Yli-Karjanmaa M; Larsen KS; Fenger CD; Kristensen LK; Martin NA; Jensen PT; Breton A; Nathanson L; Nielsen PV; Lund MC; Carlsen SL; Gramsbergen JB; Finsen B; Stubbe J; Frich LH; Stolp H; Brambilla R; Anthony DC; Meyer M; Lambertsen KL
    Brain Behav Immun; 2019 Nov; 82():279-297. PubMed ID: 31505254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.
    Hsiao HY; Chiu FL; Chen CM; Wu YR; Chen HM; Chen YC; Kuo HC; Chern Y
    Hum Mol Genet; 2014 Aug; 23(16):4328-44. PubMed ID: 24698979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic adolescent stress sex-specifically alters central and peripheral neuro-immune reactivity in rats.
    Bekhbat M; Howell PA; Rowson SA; Kelly SD; Tansey MG; Neigh GN
    Brain Behav Immun; 2019 Feb; 76():248-257. PubMed ID: 30550932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.